Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • CN Bio adds computational modeling capabilities to ADME services for enhanced bioavailability profiling

    Sep 3, 2025, 08:00 AM by
    • New PhysioMimix in silico tools unlock deeper functional insights from existing assays, advancing translation of MPS data to predict human ADME behavior • End-to-end support from experimental design to data interpretation
    Full story
  • PhenoTips Receives the Life Sciences Innovation Fund: The Ontario-based life sciences company was awarded $500,000 by the Ontario Centre of Innovation to support growth in the precision medicine marketplace

    Sep 3, 2025, 08:00 AM by
    PhenoTips, based in Toronto, has developed a first-of-its-kind cloud-based software that streamlines and digitizes genomic health record management, saving clinicians time and supporting precision medicine initiatives. In June 2025, PhenoTips was one of 13 Ontario-based life sciences companies to receive the renewed Life Sciences Innovation Fund from the government of Ontario, through the Ontario Centre of Innovation (OCI).
    Full story
  • Ametris expands collaborative research project to investigate digital measures of physical function for drug development in obesity

    Sep 3, 2025, 08:00 AM by
    Ametris (formerly ActiGraph), a global digital health solutions provider transforming real-world patient data into validated clinical evidence, announced the launch of Digital Endpoint Collaboration to accelerate Outcome DEvelopment (DECODE) in Obesity.
    Full story
  • Psilocybin Being Investigated as an Anti-Aging Agent

    Sep 3, 2025, 01:00 AM by User Not Found
    Bio-IT World| A large segment of the population holds negative views towards psychedelics, even in therapeutic contexts. Up until a few years ago, those people included Kosuke Kato, Ph.D., assistant professor of medicine at Baylor College of Medicine. His perspective changed when he and Louise Hecker, Ph.D., then working at Emory University, began reading up on the experimental use of psilocybin in treating various psychiatric and age-related neurodegenerative diseases.
    Full story
  • Machine Learning Penetrance Score Predicts Genetic Variant Impacts

    Sep 2, 2025, 01:00 AM by User Not Found
    Bio-IT World | Researchers at the Icahn School of Medicine at Mount Sinai have published a machine learning model to predict penetrance of genetic variants—how likely the variants are to cause disease. The tool combines genomic and clinical phenotype data to evaluate penetrance at scale, offering refined, individualized disease risk estimates. The study was published last week in Science (DOI: 10.1126/science.adm7066).
    Full story
  • Aptamer Group Introduces Novel Biomarker Discovery Service

    Aug 28, 2025, 10:01 AM by
    Full story
  • Qureight’s AI 3D imaging platform to support Calluna Pharma’s Phase 2 AURORA study of CAL101 in Idiopathic Pulmonary Fibrosis (IPF)

    Aug 28, 2025, 10:01 AM by
    • Qureight’s advanced AI 3D imaging platform to be used across clinical trial to evaluate anatomical lung changes in adult patients, including during patient enrolment • CAL101 is a first-in-class monoclonal antibody that neutralises the S100A4 protein, which is an upstream driver and amplifier of the multiple pro-fibrotic pathways active in IPF
    Full story
  • Advancing regenerative medicine: Cellbricks Therapeutics reaches key milestone using Rousselot biomaterials

    Aug 28, 2025, 10:01 AM by
    Rousselot announces promising preclinical results from a study conducted by Cellbricks Therapeutics, a Berlin-based biotech startup and spin-off from the Technical University of Berlin. As a pioneer in 3D-bioprinting, Cellbricks successfully implanted 3D-bioprinted adipose tissue constructs into mice, with no signs of fibrosis or rejection observed after seven weeks.
    Full story
  • Hongene to supply exNA oligonucleotide technology under new licensing deal

    Aug 28, 2025, 10:01 AM by
    Full story
  • DNAnexus Enhances Leadership to Fuel AI Innovation and Biopharma Expansion

    Aug 28, 2025, 10:01 AM by
    Company appoints Pieter De Leenheer as Chief Technology Officer and Todd Oakland as Senior Vice President and General Manager of Biopharma Business Dx/Rx
    Full story
  • Ultima’s ppmSeq Pushes Sequencing to New Levels of Accuracy

    Aug 28, 2025, 01:00 AM by User Not Found
    Bio-IT World| Ultima Genomics unveiled updates on the single-nucleotide variant (SNV) detection capabilities of its plus-minus sequencing (ppmSeq) technology, which were published at bioRxiv. The updates elaborate beyond the limits of currently available minimal residual disease assays.
    Full story
  • Huateng Pharma Expands Cosmetic Ingredients Portfolio with Reliable, Ready-to-Ship Actives

    Aug 27, 2025, 08:24 AM by
    Huateng Pharma offers reliable cosmetic ingredients including Diethylamino Hydroxybenzoyl Hexyl Benzoate, Tetrahydrocurcumin, and Piroctone Olamine.
    Full story
  • Follow the Money: Rheumatoid Arthritis Therapy, Novel Next-Gen Biosensor, More

    Aug 27, 2025, 01:00 AM by User Not Found
    Bio-IT World| SetPoint Medical will advance commercialization of the SetPoint System, a first-of-its-kind neuroimmune modulation therapy for adults living with moderate-to-severe rheumatoid arthritis; Sava Technologies plan to accelerate regulatory approval and commercialization of its next-generation wearable; and more.
    Full story
  • BioMed X, Novo Nordisk Collaboration, 10x Genomics Launches Platform Addition, More

    Aug 26, 2025, 01:00 AM by User Not Found
    Bio-IT World| BioMed X announced the launch of a new collaboration with Novo Nordisk; 10x Genomics launched Xenium Protein, a new addition to its Xenium Spatial platform; and more.
    Full story
  • eClinical Solutions Announces Integrated Data Review Plan (IDRP) Capabilities Within elluminate Platform

    Aug 22, 2025, 09:17 AM by
    Company becomes the first to centralize digital data review activities within a single platform as the industry focuses on clinical trial efficiency
    Full story
  • ZeOmega Launches Smart Auth Optimizer to Transform Prior Authorization

    Aug 21, 2025, 09:06 AM by
    Full story
  • Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia

    Aug 21, 2025, 09:06 AM by
    Full story
  • Bioprocessing Summit Honors LISURE as Best of Show Winner

    Aug 21, 2025, 01:00 AM by User Not Found
    Bio-IT World | During this week’s Bioprocessing Summit in Boston, M++ UltraPilot from LISURE was named the winner of the Best of Show People’s Choice Award competition. Other finalists and their products were also named and featured.
    Full story
  • Friends of Cancer Research and MMS Collaborate to Develop Decision Frameworks for Interim Overall Survival Data in Oncology Trials

    Aug 20, 2025, 09:21 AM by
    MMS, a global has announced that it has been chosen by Friends of Cancer Research to support the development of practical decision frameworks to inform the interpretation of interim overall survival data in oncology clinical trials.
    Full story
  • Family-Based Genomics Benchmark Promises More Accurate Variant Detection

    Aug 20, 2025, 01:00 AM by User Not Found
    Bio-IT World | A multi-generational family tree is helping researchers dramatically improve the accuracy of genomic variant calling, according to a new study published in Nature Methods. The research, led by scientists at Pacific Biosciences, introduces a comprehensive benchmarking dataset that could reshape how genomic technologies are trained and validated.
    Full story
  • «
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17 (current)
  • 18
  • 19
  • 20
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy